Literature DB >> 28859309

Artificial opsonin enhances bacterial phagocytosis, oxidative burst and chemokine production by human neutrophils.

Kristy N Katzenmeyer1, Luisa M Szott1, James D Bryers1.   

Abstract

Here, we describe the application of an 'artificial opsonin' to stimulate the innate immune response against Gram-positive bacteria. The artificial opsonin comprises a poly(L-lysine)-graft-poly(ethylene glycol) backbone displaying multiple copies of vancomycin and human IgG-Fc. The vancomycin targets bacteria by recognizing d-Ala-d-Ala-terminated peptides present in the bacterial cell wall. The human IgG-Fc antibody fragments serve as phagocyte recognition moieties that recognize the Fcγ cell surface receptors expressed by professional human phagocytes. Staphylococcus epidermidis RP62A, a biofilm-forming, methicillin-resistant strain, was utilized to investigate the effects of opsonization on phagocytosis, oxidative burst and IL-8 chemokine production by human neutrophils. Results show that opsonization of S. epidermidis RP62A with the artificial opsonin resulted in an ∼2-fold increase in neutrophil phagocytosis. Analysis of the cell supernatant found a 2- to 3-fold increase in neutrophil IL-8 secretion. The neutrophil oxidative burst was investigated using the oxidation-sensitive fluorophore dihydrorhodamine-123. Bacterial opsonization resulted in a 20% increase in fluorescence intensity, indicating a significant increase in the production of reactive oxygen species by the neutrophils. These studies suggest that artificial opsonins may be a novel immunostimulation therapeutic strategy to control infections caused by Gram-positive bacteria, particularly those that are known to be immune evasive and/or antibiotic resistant. © FEMS 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  artificial opsonin; innate response; neutrophils; phagocytosis

Mesh:

Substances:

Year:  2017        PMID: 28859309      PMCID: PMC5827578          DOI: 10.1093/femspd/ftx075

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  74 in total

Review 1.  Treatment of infections associated with surgical implants.

Authors:  Rabih O Darouiche
Journal:  N Engl J Med       Date:  2004-04-01       Impact factor: 91.245

2.  Antibiotics: vancomycin sensing.

Authors:  Michel Arthur
Journal:  Nat Chem Biol       Date:  2010-05       Impact factor: 15.040

Review 3.  Immune evasion by staphylococci.

Authors:  Timothy J Foster
Journal:  Nat Rev Microbiol       Date:  2005-12       Impact factor: 60.633

Review 4.  Staphylococcus epidermidis: emerging resistance and need for alternative agents.

Authors:  I Raad; A Alrahwan; K Rolston
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

Review 5.  Human Fc receptors: critical targets in the treatment of autoimmune diseases and transplant rejections.

Authors:  Elena Ivan; Adriana Ioana Colovai
Journal:  Hum Immunol       Date:  2006-05-11       Impact factor: 2.850

6.  Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus.

Authors:  K Sieradzki; M G Pinho; A Tomasz
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

Review 7.  Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci.

Authors:  Ana Maria Rivera; Helen W Boucher
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

8.  Targeted immunotherapy for staphylococcal infections : focus on anti-MSCRAMM antibodies.

Authors:  Michael Otto
Journal:  BioDrugs       Date:  2008       Impact factor: 5.807

Review 9.  Staphylococcal vaccines and immunotherapies.

Authors:  Adam C Schaffer; Jean C Lee
Journal:  Infect Dis Clin North Am       Date:  2009-03       Impact factor: 5.982

Review 10.  Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci.

Authors:  R Leclercq
Journal:  Clin Microbiol Infect       Date:  2009-03       Impact factor: 8.067

View more
  2 in total

1.  Induction of functional neutrophils from mouse fibroblasts by thymidine through enhancement of Tet3 activity.

Authors:  Buqing Ye; Liuliu Yang; Benyu Liu; Nian Liu; Dongdong Fan; Huimu Li; Lei Sun; Ying Du; Shuo Wang; Yong Tian; Zusen Fan
Journal:  Cell Mol Immunol       Date:  2022-03-17       Impact factor: 22.096

2.  The Stringent Response Contributes to Persistent Methicillin-Resistant Staphylococcus aureus Endovascular Infection Through the Purine Biosynthetic Pathway.

Authors:  Liang Li; Arnold S Bayer; Ambrose Cheung; Lou Lu; Wessam Abdelhady; Niles P Donegan; Jong-In Hong; Michael R Yeaman; Yan Q Xiong
Journal:  J Infect Dis       Date:  2020-09-01       Impact factor: 5.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.